Delivery Order SPE2DB20D3101-SPE2DB25FRBX8

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,531.89 firm-fixed-price contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets, with a performance period through January 2, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,455.88 and a completion date of January 3, 2024. It is a firm-fixed-price contract awarded on January 2, 2024, with no set-aside requirements indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,880.39 firm fixed-price contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of July 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4567279013 VALSARTAN-HCTZ 320-25 MG TAB 90S. The contract has a ceiling value of $3,672.98 and a completion date of February 18, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $2,626.19 and a completion date of January 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has a firm fixed price of $12,943.06 and an ultimate completion date of August 15, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, holds several Indefinite Delivery Contracts (IDCs) with various federal agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles, with a ceiling value of $11,264.80 and a performance period through January 10, 2024. The contract is a firm-fixed-price delivery order, with no set-aside requirements. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The $6,402.10 firm-fixed-price contract has a period of performance through September 16, 2024. It is not a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages, with a ceiling value of $9,564.19 and a period of performance through June 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has a ceiling value of $1,211.54 and is a firm fixed-price delivery order without a set-aside designation. The period of performance for this order extends to July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRBX8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 160-25 mg tablets. The contract has a ceiling value of $8,497.30 and is a firm-fixed price delivery order with a completion date of February 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.

Generated 5/22/25, 8:24 PM